Year: 2025
Type: dissertation
Abstract: Acute myeloid leukaemia is a cancer of the myeloid cells in the bone marrow. AML alters the bone marrow niche, creating an immunosuppressive microenvironment. AML increases tryptophan metabolism and cystine uptake. T-cells require sufficient nutrients to function. Due to a lack of clinical activity, CAR T-cell therapies are currently only used in a limited number of cancers. We hypothesised that the lack of nutrients in the AML microenvironment supresses CAR T-cell function. This work discusses how the availability of tryptophan and cystine affected T-cell and CAR T-cell proliferation. We designed CAR T-cells with the overexpression of tryptophan or cystine transporters, SLC7A5 and SLC7A11, respectively. We first demonstrated that the addition of SLC7A5 and SLC7A11 to Jurkat CAR T-cells provided increased metabolic rates in low tryptophan and cystine environments, respectively. The addition of SLC7A5 and SLC7A11 to CAR T-cells increased tryptophan and cystine uptake, respectively. CAR T-cells with SLC7A5 or SLC7A11 overexpression had increased proliferation in low tryptophan and cystine environments, respectively. The CAR T-cells with overexpression of SLC7A5 and SLC7A11 improved cancer clearance in murine models. Performing RNA sequencing of CAR-T cells following interaction with tumour cells, we showed a significant alteration of pathways associated with T-cell activation, metabolism, and migration, caused by the addition of the transporters to the CAR T-cells. These results demonstrate that the addition of SLC7A5 and SLC7A11 could improve CAR T-cell function in low amino acid environments.
Author: McJannett, Nicola Jane
Institution: University of Birmingham
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7070289406
